Surgical bleeding vs coagulopathy: the first split
Perioperative bleeding is not one diagnosis. The first question is not which product to give — it is whether the bleeding is surgical, a coagulopathy, or both.
Key points
- Perioperative bleeding is not a single diagnosis. Before treating it as a coagulation problem, decide whether the pattern fits a surgical source, a coagulopathy, or a mixed picture.
- A viscoelastic test (VET) can organize a coagulation pattern, but it does not confirm or exclude a surgical source — that comes from the surgical field.
- Surgical bleeding and coagulopathy often coexist. Source control and targeted coagulation correction may both be needed, and each must be reassessed after treatment.
When to use this page
During perioperative or post-CPB bleeding, when deciding whether the problem is primarily a surgical source, a coagulopathy, or both — before reaching for blood products.
Why this split comes first
Perioperative bleeding is not one diagnosis. The same clinical picture can be driven by a surgical source, by a coagulopathy, or by both at once. A viscoelastic test can show a coagulation pattern, but it does not replace inspection of the surgical field. Reading a VET result without confirming what the surgeon sees can send treatment in the wrong direction — for example, escalating product administration when the real problem is an open vessel.
A VET pattern is a signal, not a transfusion order
Interpret a VET pattern against the clinical situation and the bleeding pattern. A value does not mandate transfusion on its own, and a near-normal VET does not exclude bleeding. The result narrows the differential — it does not replace surgical field confirmation, physiology, or institutional protocol.
Clues that suggest surgical bleeding
- Focal bleeding from a single visible source rather than diffuse oozing across the field
- Bleeding that persists despite a corrected VET pattern
- Stable or near-normal VET results while blood loss continues
- Sudden bleeding after an anastomosis, suture line, cannulation site, drain, or a change in the operative field
- A hemodynamic pattern or surgical observation that does not fit diffuse coagulopathy
Clues that suggest coagulopathy
- Diffuse oozing or microvascular bleeding from raw surfaces, suture holes, and puncture sites at the same time
- Low fibrin-based clot firmness on the VET
- Low overall clot strength with a reduced platelet contribution
- Prolonged clotting time read in the appropriate timing window
- A lysis signal where the clot forms and then breaks down
- Predisposing physiology: dilution, hypothermia, acidosis, low ionized calcium, massive bleeding, or a relevant point in the CPB timeline
The mixed picture
Surgical bleeding and coagulation failure often coexist, and major surgical bleeding can drive a dilutional coagulopathy that then worsens oozing from the field. Correcting fibrinogen, platelets, or factors may reduce diffuse oozing, but it will not fix an active surgical source. When both are present, surgical source control and targeted coagulation correction must proceed together — neither alone is enough.
Correcting the coagulopathy does not close a vessel
If a surgical source is present, targeted replacement may improve the VET pattern while clinical bleeding continues. Persistent bleeding after the pattern is corrected should prompt a return to source control, not a reflexive second round of products.
An action frame, not an algorithm
This is a way to organize the decision — not a transfusion algorithm. The aim is to interpret each finding against the clinical situation and reassess, not to convert a single value into an automatic product order.
- Clarify the timing: CPB-in-progress, pre-protamine, post-protamine, post-CPB, or noncardiac massive bleeding — each changes interpretation
- Look at the surgical field and confirm whether a focal source is present
- Interpret the VET pattern against that clinical situation and bleeding pattern
- Consider targeted replacement of the most plausible deficit rather than broad, automatic product administration
- Correct physiology in parallel — temperature, pH, ionized calcium, and dilution
- Reassess both the test result and the actual bleeding after treatment
- If the tests improve but bleeding persists, re-check source control and reconsider a surgical cause
- Follow institutional protocol and account for local blood bank availability
Take-home message
A viscoelastic test helps organize coagulation failure, but it does not decide whether the surgeon has a bleeding source. The first split is surgical bleeding, coagulopathy, or both.
Clinical content by Kozo Watanabe, MD View profile →
Verify your decision
Once you have framed the bleeding, use the ROTEM trigger guide to organize the VET pattern — then reassess the result and the actual bleeding after treatment.
Open the ROTEM trigger guide →Continue learning
Fibrinogen first: when clot firmness is low
Low fibrin-based clot firmness can make diffuse bleeding difficult to control, but fibrinogen replacement should be interpreted as a targeted correction followed by reassessment — not an automatic order.
Heparin effect after CPB: do not confuse it with factor deficiency
A prolonged clotting time after CPB can reflect residual heparin, factor deficiency, dilution, hypothermia, sampling timing, or protamine effect. The clinical question is not simply “give more protamine.”
Platelet signal: count, function, and clot strength
A low platelet-related clot strength signal can reflect platelet number, platelet function, fibrinogen contribution, CPB-related dysfunction, antiplatelet exposure, or a mixed pattern.